Sectoral Asset Management as of June 30, 2016
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 64 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 4.8 | $46M | 1.0M | 45.45 | |
| Merck & Co (MRK) | 4.4 | $43M | 743k | 57.61 | |
| Pfizer (PFE) | 4.3 | $42M | 1.2M | 35.21 | |
| Eli Lilly & Co. (LLY) | 4.3 | $42M | 530k | 78.75 | |
| Celgene Corporation | 4.2 | $41M | 417k | 98.63 | |
| Gilead Sciences (GILD) | 4.1 | $40M | 476k | 83.42 | |
| NxStage Medical | 4.1 | $40M | 1.8M | 21.68 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $39M | 495k | 77.80 | |
| Medtronic (MDT) | 3.8 | $37M | 425k | 86.77 | |
| Abiomed | 3.4 | $33M | 298k | 109.29 | |
| Adeptus Health Inc-class A | 3.3 | $32M | 619k | 51.66 | |
| Dex (DXCM) | 3.2 | $31M | 395k | 79.33 | |
| Teva Pharmaceutical Industries (TEVA) | 3.2 | $31M | 616k | 50.23 | |
| Alexion Pharmaceuticals | 3.0 | $29M | 251k | 116.76 | |
| Portola Pharmaceuticals | 3.0 | $29M | 1.2M | 23.60 | |
| Shire | 2.8 | $27M | 148k | 184.08 | |
| Acadia Healthcare (ACHC) | 2.8 | $27M | 481k | 55.40 | |
| Amicus Therapeutics (FOLD) | 2.7 | $26M | 4.8M | 5.46 | |
| Teladoc (TDOC) | 2.4 | $24M | 1.5M | 16.02 | |
| UnitedHealth (UNH) | 2.1 | $21M | 145k | 141.20 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $20M | 232k | 86.02 | |
| Incyte Corporation (INCY) | 2.0 | $20M | 249k | 79.98 | |
| Align Technology (ALGN) | 2.0 | $20M | 246k | 80.55 | |
| Acceleron Pharma | 1.8 | $18M | 522k | 33.98 | |
| Mylan Nv | 1.8 | $18M | 408k | 43.24 | |
| Global Blood Therapeutics In | 1.7 | $16M | 987k | 16.59 | |
| Sagent Pharmaceuticals | 1.6 | $15M | 1.0M | 14.98 | |
| Alder Biopharmaceuticals | 1.4 | $13M | 525k | 24.97 | |
| Intuitive Surgical (ISRG) | 1.3 | $13M | 19k | 661.41 | |
| Novo Nordisk A/S (NVO) | 1.2 | $12M | 216k | 53.78 | |
| NuVasive | 1.0 | $9.9M | 166k | 59.72 | |
| Intercept Pharmaceuticals In | 0.8 | $7.8M | 55k | 142.69 | |
| Molina Healthcare (MOH) | 0.8 | $7.6M | 153k | 49.90 | |
| AmSurg | 0.8 | $7.5M | 96k | 77.54 | |
| Ophthotech | 0.8 | $7.5M | 147k | 51.03 | |
| Team Health Holdings | 0.7 | $7.2M | 176k | 40.67 | |
| Novavax | 0.7 | $6.6M | 912k | 7.27 | |
| Wright Medical Group Nv | 0.7 | $6.4M | 367k | 17.37 | |
| Momenta Pharmaceuticals | 0.6 | $6.2M | 574k | 10.80 | |
| Prothena (PRTA) | 0.6 | $6.1M | 175k | 34.96 | |
| Integra LifeSciences Holdings (IART) | 0.5 | $4.8M | 61k | 79.77 | |
| Surgical Care Affiliates | 0.5 | $4.7M | 98k | 47.67 | |
| Ptc Therapeutics I (PTCT) | 0.5 | $4.6M | 649k | 7.02 | |
| Accuray Incorporated (ARAY) | 0.4 | $4.3M | 826k | 5.19 | |
| Advaxis | 0.4 | $3.5M | 434k | 8.09 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $3.5M | 294k | 11.85 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $3.4M | 368k | 9.19 | |
| Entellus Medical Cm | 0.3 | $2.7M | 146k | 18.27 | |
| Uniqure Nv (QURE) | 0.3 | $2.6M | 347k | 7.37 | |
| Intersect Ent | 0.3 | $2.5M | 193k | 12.93 | |
| Lannett Company | 0.2 | $2.4M | 103k | 23.79 | |
| Neuroderm Ltd F | 0.2 | $1.7M | 105k | 16.25 | |
| Dr. Reddy's Laboratories (RDY) | 0.2 | $1.6M | 32k | 51.22 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $1.5M | 36k | 41.88 | |
| Aerie Pharmaceuticals | 0.2 | $1.6M | 88k | 17.60 | |
| Sage Therapeutics (SAGE) | 0.2 | $1.6M | 52k | 30.12 | |
| Intellia Therapeutics (NTLA) | 0.1 | $1.5M | 123k | 11.90 | |
| Pronai Therapeutics | 0.1 | $1.4M | 202k | 6.74 | |
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $960k | 30k | 32.45 | |
| Avexis | 0.1 | $976k | 26k | 38.02 | |
| China Biologic Products | 0.1 | $626k | 5.9k | 106.28 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $555k | 10k | 55.50 | |
| Seres Therapeutics (MCRB) | 0.1 | $598k | 21k | 29.03 | |
| Profound Medical | 0.1 | $607k | 542k | 1.12 |
